Using aptamers to visualize and capture cancer cells

Since diseased cells exist in exceedingly low concentration at the early stage of cancer, highly sensitive imaging and detection methods are required. By improving the methods for capturing and visualizing cancer cells, clinicians can diagnose metastatic relapse, stratify patients for therapeutic purposes, monitor response to drugs and therapies, and track tumor progression. Therefore, using advanced biotechnological and analytical methods combined with cell-SELEX (systematic evolution of ligands by exponential enrichment)-based aptamers, we improved the capture and visualization of diseased cells in a manner that is inexpensive, simple, sensitive, and fast. This multiplexed cancer detection platform therefore improves our control over a range of clinical exigencies, including cancer diagnosis, therapeutic modalities, and drug delivery systems.

[1]  S. Noguchi,et al.  Detection of Breast Cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry , 2001, Breast cancer.

[2]  Weihong Tan,et al.  Identification of liver cancer-specific aptamers using whole live cells. , 2008, Analytical chemistry.

[3]  Chad A Mirkin,et al.  Colorimetric detection of mercuric ion (Hg2+) in aqueous media using DNA-functionalized gold nanoparticles. , 2007, Angewandte Chemie.

[4]  Mehmet Toner,et al.  Enrichment using antibody-coated microfluidic chambers in shear flow: model mixtures of human lymphocytes. , 2005, Biotechnology and bioengineering.

[5]  Marie L. Sandrock and,et al.  Synthesis and Linear Optical Properties of Nanoscopic Gold Particle Pair Structures , 1999 .

[6]  S D Jayasena,et al.  Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. , 1998, Nucleic acids research.

[7]  Zeev Rosenzweig,et al.  Development of an aggregation-based immunoassay for anti-protein A using gold nanoparticles. , 2002, Analytical chemistry.

[8]  Weihong Tan,et al.  Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. , 2009, Analytical chemistry.

[9]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[10]  Yingfu Li,et al.  Simple and Rapid Colorimetric Biosensors Based on DNA Aptamer and Noncrosslinking Gold Nanoparticle Aggregation , 2007, Chembiochem : a European journal of chemical biology.

[11]  V. Rotello,et al.  Metal Directed Assembly of Terpyridine-Functionalized Gold Nanoparticles , 2002 .

[12]  Hongwei Liao and,et al.  Gold Nanorod Bioconjugates , 2005 .

[13]  C. Mirkin,et al.  Homogeneous, Nanoparticle-Based Quantitative Colorimetric Detection of Oligonucleotides , 2000 .

[14]  M. W. Vaughn,et al.  Microfluidic-based diagnostics for cervical cancer cells. , 2006, Biosensors & bioelectronics.

[15]  Chad A Mirkin,et al.  Directed Assembly of Periodic Materials from Protein and Oligonucleotide-Modified Nanoparticle Building Blocks. , 2001, Angewandte Chemie.

[16]  D. S. Coffey,et al.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.

[17]  Yu-Fen Huang,et al.  Growth of various Au–Ag nanocomposites from gold seeds in amino acid solutions , 2006 .

[18]  J. Feigon,et al.  Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Yeates,et al.  Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG). , 1996, Journal of molecular biology.

[20]  S. Jayasena,et al.  Oligonucleotide inhibitors of Taq DNA polymerase facilitate detection of low copy number targets by PCR. , 1996, Journal of molecular biology.

[21]  M Yarus,et al.  Three small ribooligonucleotides with specific arginine sites. , 1993, Biochemistry.

[22]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[23]  Chad A. Mirkin,et al.  One-Pot Colorimetric Differentiation of Polynucleotides with Single Base Imperfections Using Gold Nanoparticle Probes , 1998 .

[24]  Weihong Tan,et al.  Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. , 2009, Analytical chemistry.

[25]  George C Schatz,et al.  What controls the melting properties of DNA-linked gold nanoparticle assemblies? , 2000, Journal of the American Chemical Society.

[26]  Yanli Liu,et al.  Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. , 2007, Analytical chemistry.

[27]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[28]  D. Shangguan,et al.  Aptamers evolved from live cells as effective molecular probes for cancer study , 2006, Proceedings of the National Academy of Sciences.

[29]  Michael Famulok,et al.  Molecular Recognition of Amino Acids by RNA-Aptamers: An L-Citrulline Binding RNA Motif and Its Evolution into an L-Arginine Binder , 1994 .

[30]  L. Gold,et al.  RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Weihong Tan,et al.  Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. , 2005, Analytical chemistry.

[32]  Weihong Tan,et al.  Cancer cell targeting using multiple aptamers conjugated on nanorods. , 2008, Analytical chemistry.

[33]  Andrew D Ellington,et al.  Selection of fluorescent aptamer beacons that light up in the presence of zinc , 2008, Analytical and bioanalytical chemistry.

[34]  L. Gold,et al.  Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus. , 1996, Biochemistry.

[35]  Daniel S. Miller,et al.  Cancer incidence and mortality, 1973‐1995 , 1998 .

[36]  P. Burgstaller,et al.  RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. , 1996, Nucleic acids research.

[37]  J. Kiel,et al.  In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection. , 1999, Biosensors & bioelectronics.

[38]  Nada Jabado,et al.  Circulating tumor cells: detection, molecular profiling and future prospects , 2007, Expert review of proteomics.

[39]  J. Wills,et al.  Isolation of virus-neutralizing RNAs from a large pool of random sequences. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Mehmet Toner,et al.  Detection of mutations in EGFR in circulating lung-cancer cells. , 2008, The New England journal of medicine.

[41]  Kemin Wang,et al.  Selection of aptamers for molecular recognition and characterization of cancer cells. , 2007, Analytical chemistry.

[42]  Mehmet Toner,et al.  A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects. , 2007, Lab on a chip.

[43]  L. Gold,et al.  A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Kèlland,et al.  Discovery and development of anticancer aptamers , 2006, Molecular Cancer Therapeutics.

[45]  G. Whitesides,et al.  Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.

[46]  R. Tompkins,et al.  Effect of flow and surface conditions on human lymphocyte isolation using microfluidic chambers. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[47]  C. Mirkin,et al.  A gold-nanoparticle-based real-time colorimetric screening method for endonuclease activity and inhibition. , 2007, Angewandte Chemie.

[48]  Anne-Michelle Noone,et al.  Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  J. Storhoff,et al.  Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. , 1997, Science.

[50]  Weihong Tan,et al.  Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers , 2008, ChemMedChem.

[51]  Joshua E. Smith,et al.  Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. , 2008, Analytical chemistry.

[52]  Hui Chen,et al.  Molecular recognition of acute myeloid leukemia using aptamers , 2008, Leukemia.

[53]  V. Hornung,et al.  Ni2+-binding RNA motifs with an asymmetric purine-rich internal loop and a G-A base pair. , 1997, RNA.

[54]  Yu-Fen Huang,et al.  Synthesis and characterization of Au core-Au-Ag shell nanoparticles from gold seeds: impacts of glycine concentration and pH. , 2006, Journal of colloid and interface science.

[55]  A. Frankel,et al.  Identification of two novel arginine binding DNAs. , 1995, The EMBO journal.

[56]  N. Davidson,et al.  Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.

[57]  Thaddeus J. Norman,et al.  Ultrafast electronic relaxation and coherent vibrational oscillation of strongly coupled gold nanoparticle aggregates. , 2003, Journal of the American Chemical Society.

[58]  M. Yarus,et al.  Small RNA-divalent domains. , 1996, RNA.